Entity

Time filter

Source Type


Zhang S.,State Key Laboratory of New Technology for Chinese Medicine Pharmaceutical Process Jiangsu Kanion Pharmaceutical Co. Lianyungang 222001 China | Li Y.-J.,State Key Laboratory of New Technology for Chinese Medicine Pharmaceutical Process Jiangsu Kanion Pharmaceutical Co. Lianyungang 222001 China | Zhang C.-X.,State Key Laboratory of New Technology for Chinese Medicine Pharmaceutical Process Jiangsu Kanion Pharmaceutical Co. Lianyungang 222001 China | Huang W.-Z.,State Key Laboratory of New Technology for Chinese Medicine Pharmaceutical Process Jiangsu Kanion Pharmaceutical Co. Lianyungang 222001 China | And 4 more authors.
Biomedical Chromatography | Year: 2015

A high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (HPLC/Q-TOF MS) was developed for the analysis of chemical composition change in the production process of Re Du Ning injection, a Chinese medicine preparation with a combination of Lonicera japonica Thunb., Gardenia jasminoides Ellis and Artemisia annua L. A total of 90 compounds from raw materials-intermediates-Re Du Ning injection were detected; among them, 55 compounds were identified or tentatively characterized, and the characteristic ions of different types of compounds were described. Based on these studies, the different types of compounds in the various process routes were analyzed. A total of 28 compounds, including seven iridoid glycosides and six monoterpenes from G. jasminoides Ellis, five iridoid glycosides, nine phenolic acids and one unknown compound from L. japonica Thunb., were transferred to Re Du Ning injection, and two unknown compounds were generated in the production process of Re Du Ning injection. The results indicated that the Chinese Medicine Pharmaceutical process control is very important. This method could provide some reference for other Chinese medicine preparations. © 2015 John Wiley & Sons, Ltd. Source

Discover hidden collaborations